Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

I am new to this message board, but

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
SloDan Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 10/02/19
160x600 placeholder
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002 GlobeNewswire Inc. - 11/19/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 7:12:10 AM
Bio-Path Holdings Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/13/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:12:44 PM
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020 GlobeNewswire Inc. - 11/6/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/5/2020 4:25:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/5/2020 4:20:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:31:22 PM
Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogue... GlobeNewswire Inc. - 10/22/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:17:35 PM
Bio-Path Holdings to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Bio-Path Holdings Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/14/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2020 4:31:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:12:37 PM
Bio-Path Holdings Announces First Patient Dosed in Amended Stage 2 of the Phase 2 Clinical Trial Evaluating Prexigebersen in ... GlobeNewswire Inc. - 8/13/2020 7:00:10 AM
Bio-Path Holdings to Announce Second Quarter 2020 Financial Results on August 14, 2020 GlobeNewswire Inc. - 8/7/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/14/2020 8:20:52 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/14/2020 8:19:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2020 4:48:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 4:16:42 PM
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting GlobeNewswire Inc. - 5/29/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 7:17:29 AM
Bio-Path Holdings Reports First Quarter 2020 Financial Results GlobeNewswire Inc. - 5/15/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:31:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 4:12:24 PM
SloDan   Thursday, 10/03/19 03:27:54 PM
Re: None
Post # of 6304 
I am new to this message board, but I've been a share holder of BPTH for just under 4 yrs. now. In following this 'Message Board' it has helped me understand the history of this company. I have felt the disappointments & losses of this stock like most. I read the following article on Yahoo/Finance about BPTH's CEO a few days ago. IMO this company has been the personal PIGGY BANK for Peter Nielsen. Mid July BPTH was $17.50 ps, one can only HOPE that this Science out performs the actions and mismanagement of the CEO.
https://finance.yahoo.com/quote/BPTH/history?p=BPTH

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences